{
  "patientId": "22334",
  "demographics": {
    "name": "David Garcia",
    "dob": "1959-04-11",
    "gender": "Male",
    "address": "67 Oak Circle, Anytown, USA",
    "phone": "555-2233",
    "insurance": "Cigna",
    "referringPhysician": "Dr. Mark Johnson (Medical Oncology)",
    "emergencyContact": "Not specified in record"
  },
  "diagnosis": {
    "primary": "Pancreatic Adenocarcinoma",
    "location": "Head of Pancreas",
    "grade": "Moderately Differentiated (Grade 2)",
    "datePathologicDiagnosis": "02/01/2025 (EUS-guided Biopsy)",
    "tumorSize": "~3 cm",
    "vascularInvolvement": "Abuts SMV (<180 degrees), no SMA involvement.",
    "clinicalStage": "Borderline Resectable",
    "symptomsAtPresentation": "Painless jaundice, dark urine, mild back pain, weight loss.",
    "pathologyFindings": [
      "EUS-guided biopsy of pancreatic head mass confirms Adenocarcinoma, moderately differentiated."
    ],
    "priorProcedures": "ERCP with biliary stent placement (02/05/2025)",
    "baselineStatus": "ECOG 1",
    "priorTreatmentSummary": "Completed 4 cycles FOLFIRINOX (induction)"
  },
  "treatmentPlan": {
    "radOnc": "Dr. Robert Evans",
    "medOnc": "Dr. Mark Johnson",
    "surgOnc": "Dr. Laura Chen",
    "treatmentSite": "Pancreas Head",
    "intent": "Neoadjuvant (Pre-operative)",
    "modality": "External Beam Radiation Therapy (EBRT) with concurrent Chemotherapy (following induction chemo)",
    "rtRxDetails": "50.4 Gy in 28 fractions (1.8 Gy/fx)",
    "targetVolumeSummary": "PTV encompassing pancreatic head tumor + margin, potentially including draining nodal regions.",
    "techniqueSummary": "IMRT",
    "concurrentChemo": "Capecitabine",
    "detailedConcurrentChemo": "Capecitabine PO BID during radiation (Managed by Dr. Johnson)",
    "medications": [
      "Ondansetron PRN Nausea",
      "Loperamide PRN Diarrhea",
      "Pancreatic Enzymes (e.g., Creon) if needed for insufficiency"
    ],
    "therapistAlerts": [
        "High risk for nausea and GI side effects.",
        "Assess hydration and nutrition status daily.",
        "Patient taking oral chemotherapy (Capecitabine); reinforce compliance instructions."
    ]
  },
  "radiationOncologyData": {
    "ctSimulation": {
      "simulationDate": "05/20/2025",
      "setupInstructions": "Supine in BodyFix or VacLok bag, abdominal compression may be used. 4D-CT simulation to manage respiratory motion. SAD setup.",
      "immobilization": "BodyFix or VacLok bag, abdominal compression.",
      "referenceMarks": "3-point tattoos at isocenter projections (AP and bilateral laterals).",
      "setupImages": [
        { "type": "AP", "url": "https://placehold.co/250x200/EEE/31343C?text=AP+Setup+Photo" },
        { "type": "Lateral", "url": "https://placehold.co/250x200/EEE/31343C?text=Lateral+Setup+Photo" }
      ],
      "scanner": "Siemens Somatom go.Up",
      "sliceThickness": "2.5 mm",
      "contrastUsed": "IV Contrast and oral contrast (for bowel delineation) likely used.",
      "ctNotes": "4D-CT acquired with immobilization/compression. Motion assessed. Data acquired for IMRT planning. Fused with diagnostic CT."
    },
    "dosimetry": {
      "planId": "DG22334_Panc",
      "planStatus": "Final - Approved by Dr. Robert Evans",
      "rx": "50.4 Gy / 28 fx",
      "technique": "IMRT",
      "energy": "6MV",
      "numberOfFieldsOrArcs": 7,
      "gantryAngles": "Multiple Static",
      "collAngles": "Variable",
      "couchAngles": "0",
      "isoCoords": "L0.0, L+8.0, V-5.0",
      "tps": "Eclipse",
      "algorithm": "AcurosXB",
      "hetero": "Yes",
      "norm": "PTV Mean 95%",
      "constraints": "Kidney Mean < 18 Gy; Stomach Max < 54 Gy; Bowel Max < 54 Gy",
      "planNotes": "Neoadjuvant IMRT for borderline resectable pancreatic cancer.",
      "igrtProtocol": {
        "frequency": "Daily",
        "type": "CBCT",
        "alignment": "Soft tissue match to GTV/pancreas head."
      },
      "qaChecks": [
        { "date": "2025-05-23", "type": "Initial Chart Check", "by": "Physics Staff" },
        { "date": "2025-05-23", "type": "Patient Specific QA", "by": "Physics Staff", "result": "Pass" }
      ],
      "fieldDetails": [
        { "fieldName": "Field 1", "fieldSize": "12x14 cm", "gantryAngle": "0", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV", "monitorUnits": 62, "ssd": "88.5 cm"},
        { "fieldName": "Field 2", "fieldSize": "12x14 cm", "gantryAngle": "51", "collimatorAngle": "30", "couchAngle": "0", "energy": "6MV", "monitorUnits": 78, "ssd": "89.0 cm"},
        { "fieldName": "Field 3", "fieldSize": "12x14 cm", "gantryAngle": "102", "collimatorAngle": "330", "couchAngle": "0", "energy": "6MV", "monitorUnits": 71, "ssd": "90.0 cm"},
        { "fieldName": "Field 4", "fieldSize": "12x14 cm", "gantryAngle": "153", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV", "monitorUnits": 66, "ssd": "91.5 cm"},
        { "fieldName": "Field 5", "fieldSize": "12x14 cm", "gantryAngle": "204", "collimatorAngle": "30", "couchAngle": "0", "energy": "6MV", "monitorUnits": 72, "ssd": "90.5 cm"},
        { "fieldName": "Field 6", "fieldSize": "12x14 cm", "gantryAngle": "255", "collimatorAngle": "330", "couchAngle": "0", "energy": "6MV", "monitorUnits": 77, "ssd": "89.5 cm"},
        { "fieldName": "Field 7", "fieldSize": "12x14 cm", "gantryAngle": "306", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV", "monitorUnits": 61, "ssd": "88.0 cm"}
      ]
    },
    "treatmentDelivery": {
      "fractions": [
        { 
          "fractionNumber": 1, 
          "date": "2025-05-27", 
          "machine": "LINAC3", 
          "setupNotes":"Daily CBCT for soft tissue alignment. No shifts needed.", 
          "sideEffects": "No acute side effects.", 
          "notes": "Patient tolerated first fraction and oral capecitabine well.",
          "recordedFields": [
              {"fieldName": "Field 1", "deliveredMu": 62, "notes": "OK"},
              {"fieldName": "Field 2", "deliveredMu": 78, "notes": "OK"},
              {"fieldName": "Field 3", "deliveredMu": 71, "notes": "OK"},
              {"fieldName": "Field 4", "deliveredMu": 66, "notes": "OK"},
              {"fieldName": "Field 5", "deliveredMu": 72, "notes": "OK"},
              {"fieldName": "Field 6", "deliveredMu": 77, "notes": "OK"},
              {"fieldName": "Field 7", "deliveredMu": 61, "notes": "OK"}
          ]
        },
        { 
          "fractionNumber": 10, 
          "date": "2025-06-09", 
          "machine": "LINAC3", 
          "setupNotes":"Daily CBCT for soft tissue alignment. Shifts V:0, L:0.3, L:-0.1. Approved.", 
          "sideEffects": "Mild fatigue. Occasional nausea managed w/ Ondansetron. No significant diarrhea yet.", 
          "notes": "Tolerating concurrent chemoradiation well.",
          "recordedFields": [
              {"fieldName": "Field 1", "deliveredMu": 62, "notes": "OK"},
              {"fieldName": "Field 2", "deliveredMu": 78, "notes": "OK"},
              {"fieldName": "Field 3", "deliveredMu": 71, "notes": "OK"},
              {"fieldName": "Field 4", "deliveredMu": 66, "notes": "OK"},
              {"fieldName": "Field 5", "deliveredMu": 72, "notes": "OK"},
              {"fieldName": "Field 6", "deliveredMu": 77, "notes": "OK"},
              {"fieldName": "Field 7", "deliveredMu": 61, "notes": "OK"}
          ]
        }
      ]
    }
  },
  "imagingAndReports": [
    { "date": "01/20/2025", "type": "CT Abdomen/Pelvis w/ Contrast (Pancreas Protocol)", "summary": "3cm hypodense mass head of pancreas, abutting SMV. Dilated biliary ducts.", "reportDetails": {} },
    { "date": "01/28/2025", "type": "CT Chest", "summary": "No evidence of metastatic disease.", "reportDetails": {} },
    { "date": "02/01/2025", "type": "EUS Biopsy Report", "summary": "Adenocarcinoma consistent with pancreatic primary.", "reportDetails": {} },
    { "date": "05/15/2025", "type": "CT Abdomen/Pelvis w/ Contrast (Pancreas Protocol)", "summary": "Interval decrease in tumor size to 2.5cm. Continued abutment of SMV. Stable disease/slight response.", "reportDetails": {} },
    { "date": "05/20/2025", "type": "4D-CT Simulation (Abdomen)", "summary": "4D-CT acquired with immobilization/compression for IMRT planning.", "reportDetails": {} }
  ],
  "dicomImages": [
    { "description": "Diagnostic Pancreas Protocol CT (01/20/2025)", "seriesType": "CT", "ohifViewerUrl": "https://viewer.ohif.org/viewer?StudyInstanceUIDs=1.3.6.1.4.1.14519.5.2.1.7009.9007.298806137288633453246975630178" },
    { "description": "4D-CT Simulation (05/20/2025)", "seriesType": "CT", "ohifViewerUrl": "https://viewer.ohif.org/viewer?StudyInstanceUIDs=1.3.6.1.4.1.5962.99.1.2968617883.1314880426.1493322302363.3.0" }
  ],
  "labResults": [
    { "date": "01/20/2025", "test": "CMP - Bilirubin Total", "value": "5.2", "units": "mg/dL", "notes": "High - Consistent with biliary obstruction." },
    { "date": "01/20/2025", "test": "CMP - Alk Phos", "value": "450", "units": "U/L", "notes": "High - Consistent with biliary obstruction." },
    { "date": "01/20/2025", "test": "CA 19-9", "value": "1250", "units": "U/mL", "range": "<37", "notes": "Elevated tumor marker." },
    { "date": "02/10/2025", "test": "CMP - Bilirubin Total (Post-Stent)", "value": "1.5", "units": "mg/dL", "notes": "Improved after stenting." },
    { "date": "05/18/2025", "test": "CBC (Pre-ChemoRT)", "value": "WNL", "units": "", "notes": "Recovered from induction chemo." },
    { "date": "06/02/2025", "test": "CBC (During ChemoRT)", "value": "WBC 3.8, Plt 140k", "units": "", "notes": "Mild drop, expected Capecitabine effect." }
  ],
  "progressNotes": [
    { "date": "02/10/2025", "author": "Dr. Mark Johnson (Med Onc)", "type": "Consult Note", "summary": "Pt w/ new dx borderline resectable panc ca. ECOG 1. Stent placed. Recommend neoadjuvant FOLFIRINOX x 4 cycles then reassess for chemoradiation vs surgery. Discussed risks/benefits. Pt agrees." },
    { "date": "05/15/2025", "author": "Dr. Mark Johnson (Med Onc)", "type": "Post-Induction Note", "summary": "Pt completed 4 cycles FOLFIRINOX. Tolerated fairly well w/ dose reductions. Restaging CT shows stable/slight response, still borderline resectable. Tumor board discussion: Recommend neoadjuvant chemoradiation (Capecitabine + RT 50.4Gy). Refer back to Rad Onc. Plan for surgical eval post-CRT." },
    { "date": "05/18/2025", "author": "Dr. Robert Evans (Rad Onc)", "type": "Consult Note (Post-Induction)", "summary": "Pt s/p FOLFIRINOX for borderline panc ca. Plan for neoadjuvant CRT: IMRT 50.4Gy/28fx w/ concurrent Capecitabine. Discussed rationale, procedure, side effects (nausea, fatigue, diarrhea, potential for more severe GI tox). Pt agrees. 4D Sim scheduled." },
    { "date": "06/02/2025", "author": "Dr. Robert Evans (Rad Onc)", "type": "OTV - Week 2", "summary": "Pt completed 10/28 fx concurrent ChemoRT. Mild fatigue. Occasional nausea managed w/ Ondansetron. No significant diarrhea yet. Tolerating well. Continue plan." }
  ],
  "patientEducation": {
    "goalsDiscussed": "Neoadjuvant (pre-operative) therapy to shrink the tumor and increase the likelihood of a successful surgical resection.",
    "sideEffectsReviewed": "Fatigue, nausea, diarrhea (from both chemo and RT), potential for dehydration. Skin care in the treatment area. Hand-foot syndrome (from Capecitabine).",
    "safetyConsiderations": "Reporting fever, uncontrolled nausea/diarrhea, severe skin reaction, or significant pain. Importance of hydration and nutrition, potentially with supplements.",
    "patientResponsibilities": "Attend daily RT, take oral Capecitabine as prescribed, weekly labs and OTVs, report symptoms promptly.",
    "medicationCompliance": "Take Capecitabine with food as directed. Use anti-nausea/anti-diarrheal medications as needed."
  },
  "scheduling": [
    { "date": "01/20/2025", "time": "9 AM", "type": "CT A/P Pancreas Protocol", "location": "Radiology", "status": "Completed" },
    { "date": "02/01/2025", "time": "10 AM", "type": "EUS w/ Biopsy", "location": "Endoscopy Suite", "status": "Completed" },
    { "date": "02/05/2025", "time": "1 PM", "type": "ERCP w/ Stent", "location": "Endoscopy Suite", "status": "Completed" },
    { "date": "02/10/2025", "time": "11 AM", "type": "Med Onc Consult (Johnson)", "location": "Oncology Clinic", "status": "Completed" },
    { "date": "~02/15/2025 - ~05/10/2025", "time": "q2wks", "type": "Induction Chemo (FOLFIRINOX)", "location": "Infusion Center", "status": "Completed" },
    { "date": "05/18/2025", "time": "1 PM", "type": "Rad Onc Consult (Evans)", "location": "Rad Onc Clinic", "status": "Completed" },
    { "date": "05/20/2025", "time": "9 AM", "type": "4D-CT Simulation Abdomen", "location": "Rad Onc Sim", "status": "Completed" },
    { "date": "05/27/2025 - ~07/07/2025", "time": "Daily (M-F)", "type": "IMRT Treatment (1/28)", "location": "LINAC 3", "status": "Ongoing" }
  ],
  "cptCharges": [
    { "code": "77290", "description": "Simulation, Complex (4D-CT Abdomen)", "frequency": "Once" },
    { "code": "77334", "description": "Treatment device, Complex (BodyFix/VacLok)", "frequency": "Once" },
    { "code": "77301", "description": "IMRT planning", "frequency": "Once" },
    { "code": "77386", "description": "IMRT delivery, complex (Pancreas IMRT/VMAT)", "frequency": "Daily" },
    { "code": "77387", "description": "Image Guided RT (IGRT)", "frequency": "Daily/Weekly" },
    { "code": "77427", "description": "Radiation treatment management, 5 treatments", "frequency": "Weekly" }
  ],
  "diagnosisSearch": "Pancreatic Cancer"
}
